Biostar Pharmaceuticals, Inc. Accounts Receivable, Credit Loss Expense (Reversal)
Biostar Pharmaceuticals, Inc. reported Accounts Receivable, Credit Loss Expense (Reversal) of $0 for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2017-11-20
- Biostar Pharmaceuticals, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
- Biostar Pharmaceuticals, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- Biostar Pharmaceuticals, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2017-03-31 was -$53.50K.
- Biostar Pharmaceuticals, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2016-12-31 was -$8.09M, a 273.27% decline year-over-year.
- Biostar Pharmaceuticals, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2016 was -$265.49K, a 105.69% decline from fiscal 2015.
- Biostar Pharmaceuticals, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2015 was $4.67M.
- Biostar Pharmaceuticals, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2014 was $0.00.
- Biostar Pharmaceuticals, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2013 was -$1.29M, a 135.14% decline from fiscal 2012.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2017-09-30 | $0.00 10-Q · filed 2017-11-20 | $0.00 derived: sum of 2 quarters · filed 2017-11-20 | $0.00 10-Q · filed 2017-11-20 | -$8.14M derived: sum of 4 quarters · filed 2017-11-20 |
| 2017-06-30 | $0.00 10-Q · filed 2017-11-15 | $0.00 10-Q · filed 2017-11-15 | -$8.14M derived: sum of 3 quarters · filed 2017-11-15 | -$6.65M derived: sum of 4 quarters · filed 2017-11-20 |
| 2017-03-31 | -$53.50K 10-Q · filed 2017-05-19 | -$8.14M derived: sum of 2 quarters · filed 2017-05-19 | -$6.65M derived: sum of 3 quarters · filed 2017-11-20 | -$318.99K derived: sum of 4 quarters · filed 2017-11-20 |
| 2016-12-31 | -$8.09M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | -$6.60M derived: sum of 2 quarters · filed 2017-11-20 | -$265.49K derived: sum of 3 quarters · filed 2017-11-20 | -$265.49K 10-K · filed 2017-04-13 |
| 2016-09-30 | $1.49M 10-Q · filed 2017-11-20 | $7.82M derived: sum of 2 quarters · filed 2017-11-20 | $7.82M 10-Q · filed 2017-11-20 | $12.49M derived: sum of 4 quarters · filed 2017-11-20 |
| 2016-06-30 | $6.33M 10-Q · filed 2017-11-15 | $6.33M 10-Q · filed 2017-11-15 | $11.00M derived: sum of 3 quarters · filed 2017-11-15 | $11.00M derived: sum of 4 quarters · filed 2017-11-15 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-19 | $4.67M derived: sum of 2 quarters · filed 2017-05-19 | $4.67M derived: sum of 3 quarters · filed 2017-05-19 | $4.67M derived: sum of 4 quarters · filed 2017-05-19 |
| 2015-12-31 | $4.67M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $4.67M derived: sum of 2 quarters · filed 2017-04-13 | $4.67M derived: sum of 3 quarters · filed 2017-04-13 | $4.67M 10-K · filed 2017-04-13 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-21 | $0.00 derived: sum of 2 quarters · filed 2016-11-21 | $0.00 10-Q · filed 2016-11-21 | |
| 2015-06-30 | $0.00 10-Q · filed 2016-08-22 | $0.00 10-Q · filed 2016-08-22 | ||
| 2014-12-31 | -$2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14 | -$3.85M derived: sum of 2 quarters · filed 2016-04-14 | $0.00 10-K · filed 2016-04-14 | |
| 2014-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $2.16M 10-Q · filed 2014-11-14 | ||
| 2014-06-30 | $3.85M 10-Q · filed 2014-08-14 | |||
| 2013-12-31 | -$1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15 | -$1.29M 10-K · filed 2015-04-15 | ||
| 2013-09-30 | $0.00 10-Q · filed 2014-11-14 | |||
| 2012-12-31 | $2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $3.67M 10-K · filed 2014-03-31 | ||
| 2012-09-30 | $962.40K 10-Q · filed 2013-11-14 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-04-15 |